Skip to main content

Lyell Immunopharma Inc (LYEL) Insider Trading

In the last 90 days, 20 Lyell Immunopharma Inc (LYEL) insiders reported 14 open-market purchases totaling $349,999,884 and 6 sales totaling $28,757. The most recent open-market purchase was reported on Nov 4, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$349,999,884
Corporate buyers
14
Latest transaction
Nov 10, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Nov 10, 2026Veronica Sanchez BulisVP, Corporate ControllerSale416$15.93$6,627
Nov 10, 2026Gary K. LeeChief Scientific OfficerSale129$15.93$2,055
Nov 10, 2026Stephen J. HillChief Operating OfficerSale88$15.93$1,402
Nov 10, 2026Lynn SeelyPresident and CEOSale545$15.93$8,682
Nov 4, 2026ARCH Venture Fund IX L.P.Corporate insiderOpen Market Purchase2,321,262$10.77$24,999,992
Nov 4, 2026ARCH Venture Fund IX Overage L.P.Corporate insiderOpen Market Purchase2,321,262$10.77$24,999,992
Nov 4, 2026ARCH Venture Partners IX Overage L.P.Corporate insiderOpen Market Purchase2,321,262$10.77$24,999,992
Nov 4, 2026ARCH Venture Partners IX L.P.Corporate insiderOpen Market Purchase2,321,262$10.77$24,999,992
Nov 4, 2026ARCH Venture Partners IX LLCCorporate insiderOpen Market Purchase2,321,262$10.77$24,999,992
Nov 4, 2026Paul L BernsCorporate insiderOpen Market Purchase2,321,262$10.77$24,999,992

Common questions

LYEL insider trading FAQ

Are LYEL insiders buying or selling?
Over the last 90 days, LYEL insiders were net buyers, reporting $349,999,884 of open-market purchases and $28,757 of sales.
When was the last LYEL insider purchase?
The most recent open-market purchase of Lyell Immunopharma Inc stock by an insider was reported on Nov 4, 2026, one of 14 purchases in the last 90 days.
Where does LYEL insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Lyell Immunopharma Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.